330 related articles for article (PubMed ID: 29967342)
21. Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway.
Pan Y; Chen J; Tao L; Zhang K; Wang R; Chu X; Chen L
Oncotarget; 2017 May; 8(20):33144-33158. PubMed ID: 28388536
[TBL] [Abstract][Full Text] [Related]
22. Papillary Thyroid Cancer Tumor Spheres Cultured by Passaging Without Sorting Exhibit Cancer Stemness.
Cho JM; Lee HJ; Chung JH; Kim WY; Kang MH; Ha KS; Woo SU; Lee JB
Anticancer Res; 2020 Jul; 40(7):3801-3809. PubMed ID: 32620619
[TBL] [Abstract][Full Text] [Related]
23. Slug is a novel molecular target for head and neck squamous cell carcinoma stem-like cells.
Moon JH; Lee SH; Koo BS; Kim JM; Huang S; Cho JH; Eun YG; Shin HA; Lim YC
Oral Oncol; 2020 Dec; 111():104948. PubMed ID: 32771963
[TBL] [Abstract][Full Text] [Related]
24.
Terashima M; Ishimura A; Wanna-Udom S; Suzuki T
J Biol Chem; 2018 Nov; 293(47):18016-18030. PubMed ID: 30262664
[TBL] [Abstract][Full Text] [Related]
25. LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in papillary thyroid carcinoma.
Shen Y; Xia E; Bhandari A; Wang X; Guo G
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061172
[TBL] [Abstract][Full Text] [Related]
26. The T-box transcription factor Brachyury regulates epithelial-mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells.
Shimoda M; Sugiura T; Imajyo I; Ishii K; Chigita S; Seki K; Kobayashi Y; Shirasuna K
BMC Cancer; 2012 Aug; 12():377. PubMed ID: 22931165
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S
J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329
[TBL] [Abstract][Full Text] [Related]
28. The Role Played by SLUG, an Epithelial-Mesenchymal Transition Factor, in Invasion and Therapeutic Resistance of Malignant Glioma.
Oh SJ; Ahn EJ; Kim O; Kim D; Jung TY; Jung S; Lee JH; Kim KK; Kim H; Kim EH; Lee KH; Moon KS
Cell Mol Neurobiol; 2019 Aug; 39(6):769-782. PubMed ID: 31011939
[TBL] [Abstract][Full Text] [Related]
29. From LncRNA to metastasis: The MALAT1-EMT axis in cancer progression.
Thapa R; Afzal O; Afzal M; Gupta G; Bhat AA; Hassan Almalki W; Kazmi I; Alzarea SI; Saleem S; Arora P; Singh SK; Dua K
Pathol Res Pract; 2024 Jan; 253():154959. PubMed ID: 38029713
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers.
Jarboe T; Tuli NY; Chakraborty S; Maniyar RR; DeSouza N; Xiu-Min Li ; Moscatello A; Geliebter J; Tiwari RK
Adv Exp Med Biol; 2021; 1350():1-31. PubMed ID: 34888842
[TBL] [Abstract][Full Text] [Related]
31. Stemness is Derived from Thyroid Cancer Cells.
Ma R; Bonnefond S; Morshed SA; Latif R; Davies TF
Front Endocrinol (Lausanne); 2014; 5():114. PubMed ID: 25076938
[TBL] [Abstract][Full Text] [Related]
32. lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions.
McCabe EM; Rasmussen TP
Semin Cancer Biol; 2021 Oct; 75():38-48. PubMed ID: 33346133
[TBL] [Abstract][Full Text] [Related]
33. Cancer stem-like cells and thyroid cancer.
Guo Z; Hardin H; Lloyd RV
Endocr Relat Cancer; 2014 Oct; 21(5):T285-300. PubMed ID: 24788702
[TBL] [Abstract][Full Text] [Related]
34. High expression of LINC0163 promotes progression of papillary thyroid cancer by regulating epithelial-mesenchymal transition MITF.
Gao P; Jiao H; Zhe L; Cui J
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5504-5511. PubMed ID: 32495885
[TBL] [Abstract][Full Text] [Related]
35. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
[TBL] [Abstract][Full Text] [Related]
36. Multiple pluripotent stem cell markers in human anaplastic thyroid cancer: the putative upstream role of SOX2.
Carina V; Zito G; Pizzolanti G; Richiusa P; Criscimanna A; Rodolico V; Tomasello L; Pitrone M; Arancio W; Giordano C
Thyroid; 2013 Jul; 23(7):829-37. PubMed ID: 23301671
[TBL] [Abstract][Full Text] [Related]
37. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.
Sheng W; Chen Y; Gong Y; Dong T; Zhang B; Gao W
Oncol Rep; 2016 Dec; 36(6):3387-3396. PubMed ID: 27779717
[TBL] [Abstract][Full Text] [Related]
38. Exploiting transcription factors to target EMT and cancer stem cells for tumor modulation and therapy.
Khan AQ; Hasan A; Mir SS; Rashid K; Uddin S; Steinhoff M
Semin Cancer Biol; 2024 May; 100():1-16. PubMed ID: 38503384
[TBL] [Abstract][Full Text] [Related]
39. Missing Links in Epithelial-Mesenchymal Transition: Long Non-Coding RNAs Enter the Arena.
Wang L; Yang F; Jia LT; Yang AG
Cell Physiol Biochem; 2017; 44(4):1665-1680. PubMed ID: 29216625
[TBL] [Abstract][Full Text] [Related]
40. TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1.
Lee Y; Yoon J; Ko D; Yu M; Lee S; Kim S
J Exp Clin Cancer Res; 2021 Nov; 40(1):372. PubMed ID: 34809669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]